Variant detail

KCNQ1G186R

c.556G>C · residue 186 · Chr11 2591936
HGVS annotation

ClinVar-style identity and transcript context

ClinVar-style HGVS
NM_000218.3(KCNQ1):c.556G>C (G186R)
HGVSc
c.556G>C
cDNA change
c.556G>C
RefSeq transcript
NM_000218.3
Ensembl transcript
ENST00000155840.12
Protein HGVS
G186R
Genomic coordinate
NC_000011.10:g.2591936G>C
LQT1 penetrance High risk
61% 90% credible interval 44-76%
0%20%50%100%

Emerging evidence · n=14 12 observed LQT1 carriers · 2.59 hypothetical affected and 7.41 hypothetical unaffected

One-sentence summary

Roughly 6 in 10 people who carry G186R are estimated to eventually be diagnosed with Long QT type 1 — high risk penetrance, based on 14 carriers reported so far.

Structure: Hotspot. Functional class: NA.

Executive summary

Sources used for interpretation

The LQT1 penetrance estimate combines observed carrier counts with a feature-based model starting point. Other rows summarize supporting annotations for interpretation; not every row is a direct input to the model.

Estimatemodel output Observedmeasured in people/assays Model inputassumed, not observed Predictedcomputational Externalthird-party

Evidence

Carriers observed
14
12 LQT1 · 2 unaffected/other · 0 gnomAD
Model prior: 2.59 hypothetical affected · 7.41 hypothetical unaffected
Emerging evidence
Functional data
NA
0 published functional studies
Predictors and density
REVELLikely damaging0.951range 0-1
LQT1 densitySparse region0.423range 0-1
PolyPhen-2Probably damaging1range 0-1
PROVEANDeleterious-7.08cutoff <= -2.5
BLAST-PSSM0lower = less tolerated
Overall4/5
Range labels show the expected scale or cutoff. Calls are rough orientation from published cutoffs (hover a row) — not a clinical classification.

Automated ACMG/AMP review prompts

Generated from available data — not a clinical classification
PS3not met
Published functional studies available
PM1review
Hotspot or high LQT1 density
PM2met · moderate
Absent or extremely rare in population data
PP3met · supporting
Computational predictors support effect
BS1not met
Allele frequency too high for disorder

Reported carrier data

Paper / cohort Carriers LQT1 / affected Unaffected / ambiguous Other observations Variant context
Year 2010 · clinical carrier record
13 11 LQT1 2 asymptomatic Not separately annotated
Variant G186R
Curated carrier-count row
Year 2009 · clinical carrier record
1 1 LQT1 0 asymptomatic Not separately annotated
Variant G186R
Curated carrier-count row
gnomAD population observations (v4) 0 0 LQT1 0 Population observations; not known affected cases. gnomAD v4 allele count.
Combined literature, cohort, and gnomAD 14 12 LQT1 2 Combined totals used in the penetrance estimate. Curated carrier totals for this variant.
Hypothetical observations from model prior (not observed patients) 10 2.59 hypothetical LQT1 affected 7.41 hypothetical unaffected Feature-based pseudo-counts added before observed carriers. Model input; not literature or gnomAD evidence.

Model starting point. The penetrance model starts with 2.59 hypothetical affected and 7.41 hypothetical unaffected observations derived from variant features, then updates that starting point with the real carrier counts above. As observed carrier counts grow, this feature-based starting point has less influence.

Nearby variants · researcher detail
Neighbour residueDistance (A)Observed variants
1860.0G186R, G186D,
1853.8V185L, V185L, V185M, V185del,
1904.5R190W, R190Q, R190L,
1874.6L187P, L187F,
1894.9G189R, G189R, G189E,
1885.0W188C, W188C, W188G, W188S,
1797.3G179S,
1917.9
1848.0Y184S, Y184C, Y184D, Y184H
1788.0A178T, A178del,
1929.0R192C, R192H,
1829.6
1759.8L175I,
1939.9F193L, F193L, F193L,
18310.3K183R,
17710.9S177F,
18011.0
18111.2R181C,
17611.3
19411.7A194P, A194T,
19512.6R195Q, R195W,
10713.1Q107H, Q107H,
17213.9V172M, V172E,
11113.9Y111C,
17314.5
17114.9
External resources